Management of Glomerular Proteinuria: A Commentary

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · see citing works

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · see citing works

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663 · see citing works

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493 · see citing works

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987 · see citing works

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664 · see citing works

Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol

Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407 · see citing works

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy

Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394 · see citing works

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604 · see citing works

[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].

Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,527 · see citing works

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals

Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · see citing works

The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease

Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328 · see citing works

Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease Results From the AASK Trial

Wright, J. T. (2002) · JAMA · doi:10.1001/jama.288.19.2421 · Cited by 2,033 · see citing works

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

The GISEN Group, & MANNO, C. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11445-8 · Cited by 1,863 · see citing works

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

(2000) · The Lancet · doi:10.1016/s0140-6736(00)03307-9 · Cited by 1,790 · see citing works

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients

Flather, M. D., Yusuf, S., Køber, L., Pfeffer, M. A., Hall, A. S., Murray, G. D., Torp-Pedersen, C. T., Ball, S. G., Pogue, J. M., Moyé, L. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02212-1 · Cited by 1,580 · see citing works

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09328-5 · Cited by 1,502 · see citing works

Walking compared with vigorous exercise for the prevention of cardiovascular events in women.

Manson, J., Greenland, P., LaCroix, A., Stefanick, M., Mouton, C. P., Oberman, A., Perri, M., Sheps, D., Pettinger, M., & Siscovick, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021067 · Cited by 1,449 · see citing works

Preserving renal function in adults with hypertension and diabetes: A consensus approach

Bakris, G. L., Williams, M. E., Dworkin, L. D., Elliott, W. J., Epstein, M., Toto, R. D., Tuttle, K. R., Douglas, J. G., Hsueh, W. A., & Sowers, J. R. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16225 · Cited by 1,399 · see citing works

Blood Pressure Control, Proteinuria, and the Progression of Renal Disease

Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,325 · see citing works

A Role for Uric Acid in the Progression of Renal Disease

Kang, D., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L. D., Harris, R. C., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,306 · see citing works

Obesity-related glomerulopathy: An emerging epidemic

Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D’Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,279 · see citing works

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial

Dickstein, K., & KJEKSHUS, J. K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09895-1 · Cited by 1,200 · see citing works

A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., Brown, M. A., Jennings, G. L. R., Johnston, C. I., McNeil, J. J., Macdonald, G. J., Marley, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021716 · Cited by 1,130 · see citing works

Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease: A Meta-Analysis of Patient-Level Data

Jafar, T. H., Schmid, C. H., Landa, M., Giatras, I., Toto, R., Remuzzi, G., Maschio, G., Brenner, B. M., Kamper, A., Zucchelli, P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-2-200107170-00007 · Cited by 1,092 · see citing works

Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension

Clement, D. L., De Buyzere, M. L., De Bacquer, D. A., de Leeuw, P. W., Duprez, D. A., Fagard, R. H., Gheeraert, P. J., Missault, L. H., Braun, J. J., Six, R. O., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022273 · Cited by 1,085 · see citing works

CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

McMurray, J. J. V., Östergren, J., Swedberg, K. B., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer (2003) · The Lancet · Cited by 1,043 · see citing works

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R. J., Watts, R. W., & Cooper, M. E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1440 · Cited by 1,026 · see citing works

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

Schrier, R. W., Estacio, R. O., Esler, A. L., & Mehler, P. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00213.x · Cited by 843 · see citing works

Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States

Muntner, P., He, J., Hamm, L. L., Loria, C. M., & Whelton, P. K. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133745 · Cited by 825 · see citing works

Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes

Lurbe, E., Redón, J., Kesani, A., Pascual, J. M., Tacons, J., Álvarez, V., & BATLLE, D. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013410 · Cited by 723 · see citing works

Angiotensin II receptors

Singh, K. D., & Karnik, S. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00020-9 · Cited by 705 · see citing works

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

Modification of Diet in Renal Disease Study Group, Hunsicker, L. G., Adler, S. G., Caggiula, A. W., England, B. K., Greene, T., Kusek, J. W., Rogers, N. L., Teschan, P. E., & Beck, G. J. (1997) · Kidney International · doi:10.1038/ki.1997.260 · Cited by 698 · see citing works

Untitled work

(2000) · PubMed · Cited by 691 · see citing works

Effect of lipid reduction on the progression of renal disease: A meta-analysis

Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 664 · see citing works

Understanding the nature of renal disease progression

Remuzzi, G., Ruggenenti, P. L., & Benigni, A. (1997) · Kidney International · doi:10.1038/ki.1997.2 · Cited by 641 · see citing works

Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study

Neoptolemos, J. P., KEMPPAINEN, E., Mayer, J., Fitzpatrick, J., Raraty, M. G. T., Slavin, J. P., Beger, H.-G., Hietaranta, A. J., & Pa, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02327-8 · Cited by 621 · see citing works

Nephropathy in Patients with Type 2 Diabetes

Remuzzi, G., Schieppati, A., & Ruggenenti, P. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011773 · Cited by 584 · see citing works

Measurement of renal function in chronic renal disease

Levey, P. D. A. S. (1990) · Kidney International · doi:10.1038/ki.1990.182 · Cited by 564 · see citing works

Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity

Watanabe, S., Kang, D., Feng, L., Nakagawa, T., Kanellis, J., Lan, H. Y., Mazzali, M., & Johnson, R. J. (2002) · Hypertension · doi:10.1161/01.hyp.0000028589.66335.aa · Cited by 562 · see citing works

Progression, remission, regression of chronic renal diseases

Ruggenenti, P. L., Schieppati, A., & Remuzzi, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04728-0 · Cited by 545 · see citing works

The Effects of Weight Loss on Renal Function in Patients with Severe Obesity

Chagnac, A., Weinstein, T., Herman, M., Hirsh, J., Gafter, U., & Ori, Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068462.38661.89 · Cited by 537 · see citing works

Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure

Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504 · see citing works

Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats

Rocha, R., Chander, P. N., Khanna, K., Zuckerman, A. L., & Stier, C. T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.451 · Cited by 492 · see citing works

Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures

Svensson, P., Fairé, U. D., Sleight, P., Yusuf, S., & Östergren, J. (2001) · Hypertension · doi:10.1161/hy1101.099502 · Cited by 490 · see citing works

Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy

Sato, A., Hayashi, K., Naruse, M., & Saruta, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000044937.95080.e9 · Cited by 466 · cited 1× · see citing works

Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS

Pifer, T. B., McCullough, K. P., Port, F. K., Goodkin, D. A., Maroni, B. J., Held, P. J., & Young, E. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00658.x · Cited by 460 · see citing works

The Modification of Diet in Renal Disease Study

Klahr, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201310 · Cited by 454 · see citing works

Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists

Taal, M. W., & Brenner, B. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00031.x · Cited by 439 · see citing works

Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal Disease

Giatras, I., Lau, J., & Levey, A. S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-5-199709010-00001 · Cited by 429 · see citing works

Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy

Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J. L., Drury, P., Esmatjes, E., Hricik, D. E., Parikh, C. R., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00010 · Cited by 400 · see citing works

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

Weinberger, M. H., Roniker, B., Krause, S. L., & Weiss, R. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02957-6 · Cited by 386 · see citing works

Treatment of IgA Nephropathy with ACE Inhibitors: A Randomized and Controlled Trial

Praga, M., Gutiérrez, E., González, E., Morales, E., & Hernández, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068460.37369.dc · Cited by 345 · see citing works

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease

Bianchi, S., Bigazzi, R., Caiazza, A., & Campese, V. M. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50140 · Cited by 329 · see citing works

Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy

Hansen, H. P., Tauber-Lassen, E., Jensen, B. R., & Parving, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00421.x · Cited by 328 · see citing works

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

Morales, E., Valero, M. A., León, M., Hernández, E., & Praga, M. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50039 · Cited by 320 · see citing works

Effect of Pravastatin on Loss of Renal Function in People with Moderate Chronic Renal Insufficiency and Cardiovascular Disease

Tonelli, M. A., Moyé, L. A., Sacks, F. M., Cole, T., & Curhan, G. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068461.45784.2f · Cited by 298 · see citing works

Smoking Is Related to Albuminuria and Abnormal Renal Function in Nondiabetic Persons

Pinto‐Sietsma, S., Mulder, J., Janssen, W. M. T., Hillege, H. L., de Zeeuw, D., & de Jong, P. E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00008 · Cited by 295 · see citing works

J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data

Boutitie, F., Gueyffier, F., Pocock, S., Fagard, R. H., & Boissel, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-6-200203190-00007 · Cited by 286 · see citing works

Retarding progression of chronic renal disease: The neglected issue of residual proteinuria

Ruggenenti, P. L., Perna, A., Remuzzi, G., & Investigators of the Gisen Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00033.x · Cited by 271 · see citing works

The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.

Esther, C. R., Marino, E. M., Howard, T. E., Machaud, A., Corvol, P. L., Capecchi, M. R., & Bernstein, K. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119419 · Cited by 271 · see citing works

Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes

Ruggenenti, P., Gaspari, F., Perna, A., & Remuzzi, G. (1998) · BMJ · doi:10.1136/bmj.316.7130.504 · Cited by 264 · see citing works

Spironolactone in Addition to ACE Inhibition to Reduce Proteinuria in Patients with Chronic Renal Disease

Chrysostomou, A., & Becker, G. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451215 · Cited by 264 · see citing works

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

Schepkens, H., Vanholder, R. C., Billiouw, J.-M., & Lameire, N. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00642-8 · Cited by 255 · see citing works

ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure

Bakris, G. L., Siomos, M. Z., Richardson, D., Janssen, İ., Bolton, W. K., Hebert, L. A., Agarwal, R., & Catanzaro, D. F. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00381.x · Cited by 247 · see citing works

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

Jacobsen, P. K., Andersen, S., Rossing, K., Jensen, B. R., & Parving, H. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00940.x · Cited by 224 · see citing works

Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.

Dell’Italia, L. J., Meng, Q. C., Balcells, E., Wei, C., Palmer, R., Hageman, G. R., Durand, J., Hankes, G. H., & Oparil, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119529 · Cited by 216 · see citing works

Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.

Koya, D., Lee, I. K., Ishii, H., Kanoh, H., & King, G. L. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v83426 · Cited by 216 · see citing works

Renal dysfunction accompanying oral creatine supplements

Pritchard, N., & Kalra, P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79319-3 · Cited by 213 · see citing works

Renal handling of albumin: A critical review of basic concepts and perspective

Russo, L. M., Bakris, G. L., & Comper, W. D. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32764 · Cited by 207 · see citing works

The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide

Buter, H. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.7.1682 · Cited by 198 · see citing works

Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney Disease

Schrier, R. W., McFann, K. K., Johnson, A., Chapman, A. B., Edelstein, C. L., Brosnahan, G., Ecder, T., & Tison, L. O. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018407.60002.b9 · Cited by 197 · see citing works

The Living Donor in Kidney Transplantation

Bay, W. H., & HEBERT, L. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-719 · Cited by 197 · see citing works

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

Rossing, P. R., Hommel, E. E., Smidt, U., & Parving, H. ‐. (1994) · Diabetologia · doi:10.1007/s001250050140 · Cited by 190 · see citing works

Plasminogen activator inhibitor-1 and the kidney

Eddy, A. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00032.2002 · Cited by 188 · see citing works

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

Campbell, R. C., Sangalli, F., Perticucci, E., Aros, C., Viscarra, C., Perna, A., Remuzzi, A., Bertocchi, F., Fagiani, L., Remuzzi, G., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00832.x · Cited by 186 · see citing works

Fenofibrate Increases Creatininemia by Increasing Metabolic Production of Creatinine

Hottelart, C., El Esper, N., Rose, F., Achard, J.-M., & Fournier, A. (2002) · Nephron · doi:10.1159/000064083 · Cited by 186 · see citing works

Complement Activation Products in the Urine from Proteinuric Patients

Morita, Y., Ikeguchi, H., Nakamura, J., Hotta, N., Yuzawa, Y., & Matsuo, S. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v114700 · Cited by 186 · see citing works

Renoprotection: One or many therapies?

Hebert, L. A., Wilmer, W. A., Falkenhain, M. E., Ladson-Wofford, S. E., Nahman, N. S., & Rovin, B. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041211.x · Cited by 185 · see citing works

Inter-arm differences in blood pressure: when are they clinically significant?

Lane, D. A., Beevers, M., Barnes, N., Bourne, J., John, A., Malins, S., & Beevers, D. G. (2002) · Journal of Hypertension · doi:10.1097/00004872-200206000-00019 · Cited by 176 · see citing works

Regression of left ventricular hypertrophy in human hypertension with irbesartan

Malmqvist, K. K., Kahan, T., Edner, M., Held, C., Hägg, A., Lind, L., Müller-Brunotte, R., Nyström, F. H., Öhman, K. P., Osbakken, M. D., et al. (2001) · Journal of Hypertension · doi:10.1097/00004872-200106000-00023 · Cited by 176 · see citing works

Smoking and the Kidney

Orth, S. R. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018401.82863.fd · Cited by 176 · see citing works

Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury

Ruggenenti, P. L., Perna, A., Gherardi, G., Benini, R., & Remuzzi, G. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70054-0 · Cited by 175 · see citing works

In vivo bradykinin B2 receptor activation reduces renal fibrosis

Schanstra, J. P., Neau, E., Drogoz, P., Arévalo-Gómez, M. A., López-Novoa, J. M., Calise, D., Pécher, C., Bäder, M., Girolami, J., & Bascands, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15493 · Cited by 166 · see citing works

Dual renin-angiotensin system blockade at optimal doses for proteinuria

Laverman, G. D., Navis, G. J., Henning, R. H., de Jong, P. E., & de Zeeuw, D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00536.x · Cited by 165 · see citing works

“Strict” blood pressure control and progression of renal disease in hypertensive nephrosclerosis

Toto, R. D., Mitchell, H. C., Smith, R. D., Lee, H.-C., McIntire, D. D., & Pettinger, W. A. (1995) · Kidney International · doi:10.1038/ki.1995.361 · Cited by 164 · see citing works

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial

Wright, J., Bakris, G. L., & Greene, T. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00035-7 · Cited by 161 · see citing works

Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications

Epstein, M. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80115-3 · Cited by 157 · see citing works

Proteinuria: Its clinical importance and role in progressive renal disease

Keane, W. F. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70237-x · Cited by 150 · see citing works

High urine volume and low urine osmolality are risk factors for faster progression of renal disease

Hebert, L. A., Greene, T., Levey, A. S., Falkenhain, M. E., & Klahr, S. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00193-8 · Cited by 134 · see citing works

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension

Pedrinelli, R., Dell’Omo, G., Bello, V. D., Pontremoli, R., & Mariani, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001316 · Cited by 134 · see citing works

Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes.

Craven, P. A., DeRubertis, F. R., Kagan, V. E., Melhem, M. F., & Studer, R. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891405 · Cited by 129 · see citing works

The Verdict From ALLHAT—Thiazide Diuretics Are the Preferred Initial Therapy for Hypertension

Appel, L. J. (2002) · JAMA · doi:10.1001/jama.288.23.3039 · Cited by 128 · see citing works

The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy

Rodby, R. A., Rohde, R. D., Sharon, Z., Pohl, M. A., Bain, R. P., & Lewis, E. J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90054-3 · Cited by 128 · see citing works

Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).

Ruggenenti, P. L., Perna, A., Benini, R., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9112096 · Cited by 127 · see citing works

ACE Inhibitors versus AT1 Receptor Antagonists in Patients with Chronic Renal Disease

Hilgers, K. F., & Mann, J. F. E. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341100 · Cited by 126 · see citing works

C6 Mediates Chronic Progression of Tubulointerstitial Damage in Rats with Remnant Kidneys

Nangaku, M., Pippin, J. W., & Couser, W. G. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134928 · Cited by 125 · see citing works

Remission of nephrotic range proteinuria in type I diabetes

Hebert, L. A., Bain, R. P., Verme, D., Cattran, D. C., Whittier, F. C., Tolchin, N., Rohde, R. D., Lewis, E. J., Lewis, E. J., Rohde, R., et al. (1994) · Kidney International · doi:10.1038/ki.1994.469 · Cited by 124 · see citing works

Oral Contraceptive Use and Hormone Replacement Therapy Are Associated With Microalbuminuria

Monster, T. B. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.2000 · Cited by 120 · see citing works

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

Zoja, C., Corna, D., Rottoli, D., Cattaneo, D., Zanchi, C., Tomasoni, S., Abbate, M., & Remuzzi, G. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00332.x · Cited by 116 · see citing works

Pentoxifylline Attenuated the Renal Disease Progression in Rats with Remnant Kidney

Lin, S., Chen, Y., Chien, C., Chiang, W., Tsai, C.-C., & Tsai, T. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034909.10994.8a · Cited by 114 · see citing works

Effects of Dietary Supplementation of α-Lipoic Acid on Early Glomerular Injury in Diabetes Mellitus

Melhem, M. F., Craven, P. A., & DeRubertis, F. R. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v121124 · Cited by 113 · see citing works

Effect of Pravastatin on Proteinuria in Patients With Well-Controlled Hypertension

Lee, T., Su, S.-F., & Tsai, C. (2002) · Hypertension · doi:10.1161/01.hyp.0000022805.11288.7f · Cited by 113 · see citing works

Lowering of Microalbuminuria in Diabetic Patients by a Sympathicoplegic Agent: Novel Approach to Prevent Progression of Diabetic Nephropathy?

STROJEK, K., GRZESZCZAK, W., GÓRSKA, J., LESCHINGER, M. I., & RITZ, E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123602 · Cited by 112 · see citing works

Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis.

Nomura, A., Morita, Y., Maruyama, S., Hotta, N., Nadai, M., Wang, L., Hasegawa, T., & Matsuo, S. (1997) · Europe PMC (PubMed Central) · Cited by 108 · see citing works

Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).

Ruggenenti, P. L., Perna, A., Mosconi, L., Matalone, M., Pisoni, R. L., Gaspari, F., & Remuzzi, G. (1997) · PubMed · Cited by 106 · see citing works

Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy

Hebert, L. A., Falkenhain, M. E., Nahman, N. S., Cosio, F. G., & O’Dorisio, T. M. (1999) · American Journal of Nephrology · doi:10.1159/000013417 · Cited by 105 · see citing works

Chronic Proteinuric Nephropathies. II. Outcomes and Response to Treatment in a Prospective Cohort of 352 Patients

Ruggenenti, P. L., Perna, A., Zoccali, C., Gherardi, G., Benini, R., Testa, A., & Remuzzi, G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11188 · Cited by 104 · see citing works

Renoprotective therapy: titration against urinary protein excretion

de Jong, P. E., Navis, G. J., & de Zeeuw, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90122-8 · Cited by 103 · see citing works

Renal Interstitial Fluid Angiotensin I and Angiotensin II Concentrations during Local Angiotensin-Converting Enzyme Inhibition

Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026610.48842.cb · Cited by 103 · see citing works

Dietary phytoestrogens: A possible role in renal disease protection

Velasquez, M. T., & Bhathena, S. J. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(05)80025-3 · Cited by 101 · see citing works

and Vitamin B

Bjorkman, D. (2000) · Journal watch · doi:10.1056/jg200008010000003 · Cited by 96 · see citing works

Proteinuria and Phenotypic Change of Proximal Tubular Cells

Zoja, C., Morigi, M., & Remuzzi, G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068626.23485.e0 · Cited by 96 · see citing works

Angiotensin-converting enzyme in non-neoplastic kidney diseases

Metzger, R. P., Bohle, R. M., Pauls, K., Eichner, G., Alhenc‐Gelas, F., Danilov, S. M., & Franke, F. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00660.x · Cited by 95 · see citing works

Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift

Epstein, M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200105000-00001 · Cited by 87 · see citing works

Measurement of SC5b-9 in urine in patients with the nephrotic syndrome

Ogrodowski, J. L., Hebert, L. A., Sedmak, D. D., Cosio, F. G., Tamerius, J. D., & Kolb, W. P. (1991) · Kidney International · doi:10.1038/ki.1991.326 · Cited by 83 · see citing works

Comparison of Nifedipine Alone and With Diltiazem or Verapamil in Hypertension

Saseen, J. J., Carter, B. L., Brown, T. E., Elliott, W. J., & Black, H. R. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.109 · Cited by 82 · see citing works

The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis.

Morita, Y., Nomura, A., Yuzawa, Y., Nishikawa, K., Hotta, N., Shimizu, F., & Matsuo, S. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891363 · Cited by 82 · see citing works

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. the swiss heart study: a randomized controlled trial

Schnyder, G., Roffi, M., Flammer, Y., Pin, R., & Hess, O. M. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)01039-5 · Cited by 76 · see citing works

Urea and Creatinine Production and Excretion in Urine during and after Prolonged Heavy Exercise

Refsum, H. E., & Strømme, S. B. (1974) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517409082493 · Cited by 74 · see citing works

Diverse Effects of Increasing Lisinopril Doses on Lipid Abnormalities in Chronic Nephropathies

Ruggenenti, P. L., Mise, N., Pisoni, R., Arnoldi, F., Pezzotta, A., Perna, A., Cattaneo, D., & Remuzzi, G. (2003) · Circulation · doi:10.1161/01.cir.0000047526.08376.80 · Cited by 71 · see citing works

Glomerular Permselectivity Factors Are Not Responsible for the Increase in Fractional Clearance of Albumin in Rat Glomerulonephritis

Greive, K. A., Nikolic‐Paterson, D. J., Guimarães, M. A. M., Nikolovski, J., Pratt, L. M., Mu, W., Atkins, R. C., & Comper, W. D. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61792-0 · Cited by 65 · see citing works

Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension

Tapia, E., Franco, M., Sánchez‐Lozada, L. G., Soto, V., Ávila-Casado, C., Santamaría, J., Quiroz, Y., Rodríguez‐Iturbe, B., & Herrera-Acosta, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00811.x · Cited by 65 · see citing works

Bradykinin-Induced Reductions in Collagen Gene Expression Involve Prostacyclin

Gallagher, A. M., Yu, H., & Printz, M. P. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.84 · Cited by 64 · see citing works

Rethinking Postmenopausal Hormone Therapy

Solomon, C. G., & Dluhy, R. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030006 · Cited by 64 · see citing works

Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-facp) rats

Tofovic, S. P., Kost, C. K., Jackson, E. K., & Bastacky, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00278.x · Cited by 63 · see citing works

Cigarette smoke condensate aggravates renal injury in the renal ablation model

Odoni, G., Ogata, E., Viedt, C., Amann, K., Ritz, E., & Orth, S. R. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00382.x · Cited by 62 · see citing works

Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure

Farquharson, C. A. J., & Struthers, A. D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01689-3 · Cited by 61 · see citing works

Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats

Attia, D. M., Ni, Z., de Boer, P., Attia, M. A., Goldschmeding, R., Koomans, H. A., Vaziri, N. D., & Joles, J. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00313.x · Cited by 61 · see citing works

Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy

Andersen, S., Tarnow, L., Cambien, F., Rossing, P. R., Juhl, T. R., Deinum, J., & Parving, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1501 · Cited by 58 · see citing works

A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease

Vasavada, N., Saha, C., & Agarwal, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00124.x · Cited by 56 · see citing works

High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent

Schrijvers, B. F., Rasch, R., Tilton, R. G., & Flyvbjerg, A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00310.x · Cited by 55 · see citing works

Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients

Giordano, M., Feo, P. D., Lucidi, P., dePascale, E., Giordano, G., Cirillo, D., Dardo, G., Signorelli, S. S., & Castellino, P. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00791.x · Cited by 55 · see citing works

Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.

van der Kleij, F. G., Schmidt, A., Navis, G., Haas, M., Yilmaz, N., de Jong, P. E., Mayer, G. J., & de Zeeuw, D. (1997) · PubMed · Cited by 55 · see citing works

Impact of Treatment of Dyslipidemia on Renal Function, Fat Deposits and Scarring in Patients with Persistent Nephrotic Syndrome

Gheith, O. A. A., Sobh, M. A. K., Mohamed, K. E.-S., El-Baz, M. A., El-Husseini, F., Gazarin, S. S., Ahmed, H. A.-E.-H., Rasem, M. W., & Amer, G. M. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000065021 · Cited by 53 · see citing works

The ALLHAT Report: A Case of Information and Misinformation

Weber, M. A. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.02287.x · Cited by 51 · see citing works

Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies

Ruggenenti, P., Perna, A., Mosconi, L., Matalone, M., Pisoni, R., Gaspari, F., & Remuzzi, G. (1997) · Kidney International · Cited by 50 · see citing works

Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells

Tang, S. C. W., Lai, K. N., Chan, T. M., Lan, H. Y., Ho, S. K., & Sacks, S. H. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.20593 · Cited by 49 · see citing works

A circadian rhythm of proteinuria in patients with a nephrotic syndrome

Koopman, M. G., Krediet, R. T., Zuyderhoudt, F. M. J., de Moor, E., & Arisz, L. (1985) · Clinical Science · doi:10.1042/cs0690395 · Cited by 48 · see citing works

Treatment of Severe Nephrotic Syndrome With Meclofenamate: An Uncontrolled Pilot Study

Velosa, J. A., Torres, V. E., Donadío, J. V., Wagoner, R. D., Holley, K. E., & Offord, K. P. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60980-x · Cited by 40 · see citing works

ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy

Ha, S., Park, H. C., Park, H. S., Kang, B. S., Lee, T. H., Hwang, H. J., Kim, S. J., Kim, D. H., Kang, S., Choi, K. H., et al. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00191-4 · Cited by 37 · see citing works

Eplerenone reduces proteinuria in type II diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction

Epstein, M., Buckalew, V. M., Altamirano, J. H., Roniker, B., Krause, S. L., & Kleiman, J. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)81115-9 · Cited by 36 · see citing works

Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis

Branten, A. J. W., van den Born, J., Jansen, J. L. J., Assmann, K. J. M., Wetzels, J. F. M., & Dijkman, W. T. T. A. O. H. B. P. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002693.x · Cited by 35 · see citing works

Sodium bicarbonate treatment reduces renal injury, renal production of transforming growth Factor-β, and urinary transforming growth Factor-β excretion in rats with doxorubicin-induced nephropathy

Baroni, E. A., Costa, R. S., Volpini, R. A., & Coimbra, T. M. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70363-x · Cited by 34 · see citing works

Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis

Iodice, C., Balletta, M., Minutolo, R., Giannattasio, P., Tuccillo, S., Bellizzi, V., D’Amora, M., Rinaldi, G., Signoriello, G., Conte, G., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00015.x · Cited by 34 · see citing works

Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype?

Andersen, S., Tarnow, L., Cambien, F., Rossing, P. R., Juhl, T. R., Deinum, J., & Parving, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00410.x · Cited by 33 · see citing works

Are COX-2 selective inhibitors nephrotoxic?

Mj, D. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70274-5 · Cited by 33 · see citing works

The Expanding Role of Angiotensin Converting Enzyme Inhibitors in the Management of Hypertension

Burris, J. F. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04070.x · Cited by 32 · see citing works

Antiproteinuric effect of niceritrol, a nicotinic acid derivative, in chronic renal disease with hyperlipidemia: a randomized trial

Owada, A., Suda, S., & Hata, T. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01567-x · Cited by 30 · see citing works

Effect of selenium-deficient diet in experimental glomerular disease

Baliga, R., Baliga, M., & Shah, S. V. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.1.f56 · Cited by 30 · see citing works

Dietary protein intake significantly affects the serum creatinine concentration

Butani, L., Polinsky, M. S., Kaiser, B. A., & Baluarte, H. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00342.x · Cited by 29 · see citing works

Circadian rhythm in glomerular transport of macromolecules through large pores and shunt pathway

Koopman, M. G., Koomen, G. C. M., van Acker, B. A. C., & Arisz, L. (1996) · Kidney International · doi:10.1038/ki.1996.178 · Cited by 28 · see citing works

Effect of high dose ramipril with or without indomethacin on glomerular selectivity

Pisoni, R., Ruggenenti, P. L., Sangalli, F., Lepre, M. S., Remuzzi, A., & Remuzzi, G. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00535.x · Cited by 26 · see citing works

ACUTE AND CHRONIC EFFECTS OF ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS ON TISSUE ANGIOTENSIN‐CONVERTING ENZYME

Chai, S. Y., Perich, R. B., Jackson, B., Mendelsohn, F. A. O., & Johnston, C. I. (1992) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1992.tb02803.x · Cited by 26 · see citing works

Kidney iron status in passive Heymann nephritis and the effect of an iron-deficient diet.

Baliga, R., Ueda, N., & Shah, S. V. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v781183 · Cited by 24 · see citing works

Adverse Effect of Exercise on Immune Complex-Mediated Glomerulonephritis

Cornacoff, J. B., Hebert, L. A., Sharma, H. M., Bay, W. H., & Young, D. C. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183481 · Cited by 24 · see citing works

Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy

Haas, M., Leko-Mohr, Z., Erler, C., & Mayer, G. J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34883 · Cited by 24 · see citing works

Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study

Yıldız, A., Hursit, M., Celik, A., Kayacan, S. M., Yazıcı, H., Akkaya, V., Gurol, A., & Karsidag, K. (2002) · Clinical Nephrology · doi:10.5414/cnp58405 · Cited by 17 · see citing works

MRC/BHF Heart Protection Study

Collins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11692-8 · Cited by 13 · see citing works

High-dose ACE inhibition: Can it improve renoprotection?

Navis, G. J., Kramer, A. B., & de Jong, P. E. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36005 · Cited by 13 · see citing works

Attenuating effect of a semipurified alcohol extract of soy protein on glomerular injury in spontaneous hypercholesterolemic male Imai rats

Sakemi, T., Ikeda, Y., Shimazu, K., & Uesugi, T. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80133-5 · Cited by 13 · see citing works

Effect of VDR gene polymorphisms on osteocalcin secretion in calcitriol-stimulated human osteoblasts

Naves‐Díaz, M., Álvarez-Hernández, D., Martín, J. L. F., Paz-Jiménez, J., García-Prado, P., Fernández‐Coto, T., Santamaría, Í., & Cannata-Andía, J. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s85.7.x · Cited by 12 · see citing works

ACE inhibitors and AT1 receptor antagonists: Is two better than one?

Noris, M., & Remuzzi, G. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00261.x · Cited by 12 · see citing works

Management of Lupus Nephropathy

Hebert, L. A. (2003) · Nephron Clinical Practice · doi:10.1159/000066645 · Cited by 11 · see citing works

Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease

Hebert, L. A. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0063-0 · Cited by 7 · see citing works

SELECTIVITY AS A CLUE TO DIAGNOSIS OF POSTURAL PROTEINURIA

Fj, F., Frey, B., Koegel, R., Hodler, J., & Wegmüller, E. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92888-5 · Cited by 7 · see citing works

Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach

Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,391 · see citing works

KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease

de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399 · see citing works

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

Ogihara, T., Kikuchi, K., Matsuoka, H., Fujita, T., Higaki, J., Horiuchi, M., Imai, Y., Imaizumi, T., Ito, S., Iwao, H., et al. (2009) · Hypertension Research · doi:10.1038/hr.2014.68 · Cited by 1,094 · see citing works

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373 · see citing works

KDIGO Clinical Practice Guideline for Glomerulonephritis

Eckardt, K., & Kasiske, B. L. (2012) · Cited by 866 · see citing works

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

Kunz, R., Friedrich, C., Wolbers, M., & Mann, J. F. E. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00190 · Cited by 713 · see citing works

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

Palmer, B. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035279 · Cited by 640 · see citing works

Cell Biology and Pathology of Podocytes

Greka, A., & Mundel, P. H. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153238 · Cited by 519 · see citing works

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

Remuzzi, G., Perico, N., Macia, M. L., & Ruggenenti, P. L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09911.x · Cited by 505 · see citing works

Progression of nephropathy in type 2 diabetic patients

Rossing, K., Christensen, P. K., Hovind, P. H., Tarnow, L., Rossing, P. R., & Parving, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00925.x · Cited by 338 · see citing works

Primary glomerulonephritides

Floege, J., & Amann, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00272-5 · Cited by 306 · see citing works

Proteinuria: an enzymatic disease of the podocyte?

Mundel, P. H., & Reiser, J. (2009) · Kidney International · doi:10.1038/ki.2009.424 · Cited by 267 · see citing works

Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity

Rovin, B. H., Song, H., Birmingham, D. J., Hebert, L. A., Yu, C. Y., & Nagaraja, H. N. (2004) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080658 · Cited by 266 · see citing works

Proteinuria: detection and role in native renal disease progression

Górriz, J. L., & Martínez‐Castelao, A. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.10.002 · Cited by 256 · see citing works

Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)

Guidelines, S. (2006) · Hypertension Research · Cited by 216 · see citing works

Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)

Japanese Society of Hypertension (2006) · Hypertension Research · doi:10.1291/hypres.29.s1 · Cited by 216 · see citing works

Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia

Hsu, T.-W., Liu, J., Hung, S., Kuo, K., Chang, Y., Chen, Y., Hsu, C.-C., & Tarng, D. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12700 · Cited by 214 · see citing works

Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker

Chrysostomou, A., Pedagogos, E., MacGregor, L., & Becker, G. J. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01040905 · Cited by 208 · see citing works

Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus

Rovin, B. H., Song, H., Hebert, L. A., Nádasdy, T., Nadasdy, G. M., Birmingham, D. J., Yu, C. Y., & Nagaraja, H. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00601.x · Cited by 154 · see citing works

Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial

Cardiel, M. H., Tumlin, J. A., Furie, R. A., Wallace, D. J., Joh, T., & Linnik, M. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23673 · Cited by 147 · see citing works

Surrogate End Points for Clinical Trials of Kidney Disease Progression

Stevens, L. A., Greene, T., & Levey, A. S. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00600206 · Cited by 131 · see citing works

Assessing proteinuria in chronic kidney disease: protein-creatinine ratio versus albumin-creatinine ratio

Methven, S., MacGregor, M. S., Traynor, J. P., O’Reilly, D. S. J., & Deighan, C. J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq140 · Cited by 126 · see citing works

Timed Urine Collections Are Not Needed to Measure Urine Protein Excretion in Clinical Practice

Gaspari, F., Perico, N., & Remuzzi, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.014 · Cited by 125 · see citing works

Hyperkalemia in Heart Failure

Sarwar, C. M. S., Papadimitriou, L., Pitt, B., Piña, I. L., Zannad, F. M., Anker, S. D., Gheorghiade, M., & Butler, J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.060 · Cited by 116 · see citing works

Therapeutic strategies to slow chronic kidney disease progression

Wühl, E., & Schaefer, F. S. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0789-y · Cited by 108 · see citing works

Diabetic Nephropathy: The Proteinuria Hypothesis

Williams, M. E. (2005) · American Journal of Nephrology · doi:10.1159/000084286 · Cited by 107 · see citing works

Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature

Pisani, A., Visciano, B., Diez‐Roux, G., Sabbatini, M., Porto, C., Parenti, G., & Imbriaco, M. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.08.003 · Cited by 100 · see citing works

Current Therapy for IgA Nephropathy

Floege, J., & Eitner, F. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011030221 · Cited by 92 · see citing works

Treatment of IgA nephropathy and Henoch–Schönlein nephritis

Floege, J., & Feehally, J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.59 · Cited by 89 · see citing works

Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis.

Christopher‐Stine, L., Petri, M., Astor, B. C., & Fine, D. M. (2004) · PubMed · Cited by 87 · see citing works

Proteinuria as a Therapeutic Target in Patients with Chronic Kidney Disease

Palmer, B. F. (2007) · American Journal of Nephrology · doi:10.1159/000101958 · Cited by 82 · see citing works

Mycophenolate therapy of SLE membranous nephropathy

Spetie, D. N., Tang, Y., Rovin, B. H., Nádasdy, T., Nadasdy, G. M., Pesavento, T. E., & Hebert, L. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66030.x · Cited by 82 · see citing works

Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression

Catapano, F., Chiodini, P., Nicola, L. D., Minutolo, R., Zamboli, P., Gallo, C., & Conte, G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.008 · Cited by 82 · see citing works

ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials

Cheng, J., Zhang, W., Zhang, X. H., He, Q., Tao, X. J., & Jh, C. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02038.x · Cited by 75 · see citing works

Peripheral blood dendritic cells and GM-CSF as an adjuvantfor hepatitis B vaccination in hemodialysis patients

Verkade, M. A., van de Wetering, J., Klepper, M., Vaessen, L. M. B., Weimar, W. W., & Betjes, M. G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00781.x · Cited by 75 · see citing works

The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy

Feriozzi, S., Torrás, J., Cybulla, M., Nicholls, K., Sunder–Plassmann, G., & West, M. L. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03130411 · Cited by 75 · see citing works

Supportive Versus Immunosuppressive Therapy of Progressive IgA Nephropathy (STOP) IgAN trial: rationale and study protocol

Eitner, F., Ackermann, D., Hilgers, R.-D., & Floege, J. (2008) · Journal of Nephrology · doi:10.1093/joneph/21.3.284 · Cited by 74 · see citing works

Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares

Birmingham, D. J., Rovin, B. H., Shidham, G. B., Nagaraja, H. N., Zou, X., Bissell, M. G., Yu, C. Y., & Hebert, L. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002421 · Cited by 71 · see citing works

Chronic renal allograft injury: early detection, accurate diagnosis and management

Pascual, J., Pérez‐Sáez, M. J., Mir, M., & Crespo, M. (2012) · Transplantation Reviews · doi:10.1016/j.trre.2012.07.002 · Cited by 71 · see citing works

Systemic lupus international collaborating clinics renal activity/response exercise: Development of a renal activity score and renal response index

Petri, M., Kasitanon, N., Lee, S., Link, K., Magder, L. S., Bae, S., Hanly, J. G., Isenberg, D. A., Nived, O., Sturfelt, G. K., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23456 · Cited by 70 · see citing works

Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy

Rovin, B. H., Tang, Y., Sun, J., Nagaraja, H. N., Hackshaw, K. V., Gray, L., Rice, R. R., Birmingham, D. J., Yu, C. Y., Spetie, D. N., et al. (2005) · Kidney International · doi:10.1016/s0085-2538(15)50895-8 · Cited by 64 · see citing works

Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions

Pascual, J., Boletis, I. N., & Campistol, J. M. (2006) · Transplantation Reviews · doi:10.1016/j.trre.2005.10.005 · Cited by 62 · see citing works

Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse

Tanabe, K., Lanaspa, M. A., Kitagawa, W., Rivard, C. J., Miyazaki, M., Klawitter, J., Schreiner, G. F., Saleem, M. A., Mathieson, P. W., Makino, H., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00596.2011 · Cited by 56 · see citing works

Chapter 12: Lupus nephritis

(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.25 · Cited by 55 · see citing works

Oral Cyclophosphamide for Lupus Glomerulonephritis

McKinley, A. M., Park, E., Spetie, D. N., Hackshaw, K. V., Nagaraja, S., Hebert, L. A., & Rovin, B. H. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02670409 · Cited by 54 · see citing works

Timed Urine Collections Are Not Needed to Measure Urine Protein Excretion in Clinical Practice

Shidham, G. B., & Hebert, L. A. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.013 · Cited by 52 · see citing works

FVB mouse genotype confers susceptibility to OVE26 diabetic albuminuria

Xu, J., Huang, Y., Li, F., Zheng, S., & Epstein, P. N. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00018.2010 · Cited by 51 · see citing works

Managing kidney disease with blood-pressure control

Wühl, E., & Schaefer, F. S. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.73 · Cited by 47 · see citing works

Plasmapheresis for the Prophylaxis and Treatment of Recurrent Focal Segmental Glomerulosclerosis Following Renal Transplant

Valdivia, P., Roncero, F. G., Gentil, M. A., Jiménez, F., Algarra, G., Pereira, P., Rivera, M., Suñer, M., Cabello, V., Toro, J., et al. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.02.061 · Cited by 47 · see citing works

Membranous Lupus Nephritis: A Clinical Review

Almaani, S. J., & Parikh, S. V. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.08.009 · Cited by 47 · see citing works

Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?

Meyrier, A. Y. (2009) · Kidney International · doi:10.1038/ki.2009.204 · Cited by 45 · see citing works

Screening for chronic kidney disease in emerging countries: feasibility and hurdles

Perico, N., Bravo, R. F., León, F. R. D., & Remuzzi, G. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp039 · Cited by 45 · see citing works

Boldine Improves Kidney Damage in the Goldblatt 2K1C Model Avoiding the Increase in TGF-β

Gómez, G. I., & Velarde, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071864 · Cited by 42 · see citing works

Random Spot Urine Protein/Creatinine Ratio Is Unreliable for Estimating 24-Hour Proteinuria in Individual Systemic Lupus Erythematosus Nephritis Patients

Hebert, L. A., Birmingham, D. J., Shidham, G. B., Rovin, B. H., Nagaraja, H. N., & Yu, C. Y. (2009) · Nephron Clinical Practice · doi:10.1159/000232599 · Cited by 41 · see citing works

Assessment of proteinuria level in nephrology patients using a machine learning approach

Scala, A., Loperto, I., Carrano, R., Federico, S., Triassi, M., & Improta, G. (2021) · International Conference on Medical and Health Informatics (ICMHI) · doi:10.1145/3472813.3472816 · Cited by 40 · see citing works

Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis

Cheng, J.-W., Zhang, X., Tian, J., Li, Q., & Chen, J.-M. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02970.x · Cited by 40 · see citing works

Detection and measurement of urinary protein

Polkinghorne, K. R. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000247502.49044.10 · Cited by 39 · see citing works

Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT): Rationale and Study Design

Imai, E., Ito, S., Haneda, M., Chan, J. C. N., & Makino, H. (2006) · Hypertension Research · doi:10.1291/hypres.29.703 · Cited by 38 · see citing works

Proteinuria and Microalbuminuria in Adults: Significance, Evaluation, and Treatment

Venkat, K. K. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000140833.51533.46 · Cited by 37 · see citing works

Relationship between Albuminuria and Total Proteinuria in Systemic Lupus Erythematosus Nephritis

Birmingham, D. J., Rovin, B. H., Shidham, G. B., Bissell, M. G., Nagaraja, H. N., & Hebert, L. A. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04761107 · Cited by 36 · see citing works

Primary Care Approach to Proteinuria

Naderi, A. S. A., & Reilly, R. F. (2008) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2008.06.070080 · Cited by 35 · see citing works

Simvastatin protection against acute immune-mediated glomerulonephritis in mice

CHRISTENSEN, M. B., Su, A. W., Snyder, R. W., Greco, A. J., Lipschutz, J. H., & Madaio, M. P. (2006) · Kidney International · doi:10.1038/sj.ki.5000086 · Cited by 34 · see citing works

Norcantharidin Ameliorates Proteinuria, Associated Tubulointerstitial Inflammation and Fibrosis in Protein Overload Nephropathy

Liu, F. Y., Li, Y., Peng, Y., Ye, K., Li­, ­., Liu, Y., Duan, S., Ling, G., Xu, X., & Zhou, L. (2008) · American Journal of Nephrology · doi:10.1159/000112850 · Cited by 34 · see citing works

A Review of the Potential Benefits of Pentoxifylline in Diabetic and Non-Diabetic Proteinuria

Badri, S., Dashti‐Khavidaki, S., Lessan‐Pezeshki, M., & Abdollahi, M. R. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3bp4g · Cited by 32 · see citing works

An update on the treatment options for focal segmental glomerulosclerosis

Meyrier, A. Y. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902754029 · Cited by 31 · see citing works

Slowing the Progression of Adult Chronic Kidney Disease

Taal, M. W. (2004) · Drugs · doi:10.2165/00003495-200464200-00002 · Cited by 31 · see citing works

Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease

Prabakaran, T., Birn, H., Bibby, B. M., Regeniter, A., Sørensen, S. S., Feldt-Rasmussen, U., Nielsen, R., & Christensen, E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft452 · Cited by 30 · see citing works

Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy

Ichimura, K., Kawashima, Y., Nakamura, T., Powell, R., Hidoh, Y., Terai, S., Sakaida, I., Kodera, Y., Tsuji, T., Ma, J., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.053 · Cited by 28 · see citing works

Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood

Mastrangelo, A., Serafinelli, J., Giani, M., & Montini, G. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00205 · Cited by 27 · see citing works

Recent changes in the landscape of combination RAS blockade

Epstein, B. J., Smith, S. M., & Choksi, R. R. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.127 · Cited by 27 · see citing works

Navigating Between the Scylla and Charybdis of Prescribing Dietary Protein for Chronic Kidney Diseases

Franch, H. A., & Mitch, W. E. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141051 · Cited by 26 · see citing works

Renal protection in IgA nephropathy requires strict blood pressure control

Nagy, J., Kovács, T., & Wittmann, I. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh920 · Cited by 26 · see citing works

Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down

Trimarchi, H. (2015) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214809666150302104542 · Cited by 25 · see citing works

Effect of Add-on Pentoxifylline on Proteinuria in Membranous Glomerulonephritis: A 6-month Placebo-controlled Trial

Badri, S., Dashti‐Khavidaki, S., Ahmadi, F., Mahdavi‐Mazdeh, M., Abbasi, M.-R., & Khalili, H. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0057-1 · Cited by 25 · see citing works

Focal and Segmental Glomerulosclerosis: Multiple Pathways Are Involved

Meyrier, A. Y. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.06.003 · Cited by 24 · see citing works

Immune Modulating Therapy for IgA Nephropathy: Rationale and Evidence

Floege, J., & Eitner, F. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.10.005 · Cited by 24 · see citing works

My Doctor Said I Should Drink a Lot! Recommendations for Fluid Intake in Patients with Chronic Kidney Disease

Wenzel, U. O., Hebert, L. A., Stahl, R. A. K., & Krenz, I. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01140905 · Cited by 24 · see citing works

Optimizing ACE-Inhibitor Therapy for Chronic Kidney Disease

Hebert, L. A. (2006) · New England Journal of Medicine · doi:10.1056/nejme058295 · Cited by 24 · see citing works

Treatment of Primary Chronic Glomerulonephritis with Rehmannia Glutinosa Acteosides in Combination with the Angiotensin Receptor Blocker Irbesartan: A Randomized Controlled Trial

Qiu, H., Fu, P., Fan, W., Zuo, C., Feng, P., Shi, P., Cao, L., Liu, F., Zhou, L., Chen, F., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.4973 · Cited by 23 · see citing works

Nutritional treatment in chronic kidney disease: the concept of nephroprotection

Riccio, E., Nuzzi, A. D., & Pisani, A. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1041-7 · Cited by 23 · see citing works

Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria

Borba, E. F., Guedes, L. K. N., Christmann, R., Figueiredo, C. P., Gonçalves, C. R., & Bonfá, E. (2006) · Rheumatology International · doi:10.1007/s00296-006-0142-3 · Cited by 23 · see citing works

General acteoside of rehmanniae leaves in the treatment of primary chronic glomerulonephritis: A randomized controlled trial

Qiu, H., Fan, W., Fu, P., Zuo, C., Feng, P., Liu, F., Zhou, L., Chen, F., Zhong, H., Liang, Y., et al. (2013) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v10i4.18 · Cited by 22 · see citing works

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan

Makhlough, A., Kashi, Z., Akha, O., Zaboli, E., & Charati, J. Y. (2014) · Nephro-Urology Monthly · doi:10.5812/numonthly.12148 · Cited by 22 · see citing works

Anaplastic Lymphoma Kinase activating mechanisms and signaling pathways

Inghirami, G. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/441 · Cited by 22 · see citing works

Norcantharidin, a protective therapeutic agent in renal tubulointerstitial fibrosis

Li, Y., Ge, Y. L., Liu, F. Y., Peng, Y., Sun, L., Li, J., Chen, Q., Sun, Y., & Ye, K. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1091-z · Cited by 21 · see citing works

Introduction to Glomerular Disease

Floege, J., & Feehally, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00015-0 · Cited by 21 · see citing works

Factors influencing reported rates of treated end-stage renal disease

McDonald, S. P., McCredie, M. R. E., Williams, S., & Stewart, J. H. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2004.10.011 · Cited by 21 · see citing works

Machine-learning enhancement of urine dipstick tests for chronic kidney disease detection

Jang, E. C., Park, Y. M., Han, H. W., Lee, C. S., Kang, E. S., Lee, Y. H., & Nam, S. M. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad051 · Cited by 20 · see citing works

Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy

Kobayashi, S., Amano, H., Terawaki, H., Ogura, M., Kawaguchi, Y., & Yokoo, T. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1486-8 · Cited by 20 · see citing works

Retarding Progression of Kidney Disease

Brown, C., Haddad, N. F., & Hebert, L. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00076-9 · Cited by 20 · see citing works

To Treat or Not to Treat? Cost-Effectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective

Adarkwah, C. C., Gandjour, A., Akkerman, M. K., & Evers, S. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000350142 · Cited by 19 · see citing works

The Kidney: Medical Nutrition Therapy—Yesterday and Today

Kalista-Richards, M. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611399923 · Cited by 19 · see citing works

Urine liver fatty acid binding protein and chronic kidney disease progression

Khatir, D. S., Bendtsen, M. D., Birn, H., Nørregaard, R., Ivarsen, P., Jespersen, B., & Buus, N. H. (2017) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2017.1355561 · Cited by 19 · see citing works

ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?

Lewis, E. J., & Lewis, J. B. (2004) · PubMed · Cited by 19 · see citing works

Minor Glomerular Abnormalities are Associated with Deterioration of Long-Term Kidney Function and Mitochondrial Injury

Yu, B. C., Cho, N., Park, S., Kim, H., Gil, H., Lee, E. Y., Kwon, S. H., Jeon, J. S., Noh, H., Han, D. C., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010033 · Cited by 18 · see citing works

Guía de la Sociedad Española de Nefrología sobre riñón y enfermedad cardiovascular.: Versión Abreviada

Marin, R., Goicoechea, M., Gorostidi, M., Cases, A., Dı́ez, J., Escolar, G., Fernández-Vega, F., Palomar, R., Rodrigo, E., Martínez, I., et al. (2006) · Nefrología · Cited by 18 · see citing works

Épidémiologie des maladies rénales chroniques

Frimat, L., Loos-Ayav, C., Briançon, S., & Kessler, M. (2005) · EMC - Néphrologie · doi:10.1016/j.emcnep.2005.09.003 · Cited by 22 · see citing works

Limited Reliability of the Spot Urine Protein/Creatinine Ratio in the Longitudinal Evaluation of Patients With Lupus Nephritis

Shidham, G. B., Ayoub, I. M., Birmingham, D. J., Hebert, P. L., Rovin, B. H., Diamond, B., Wofsy, D., & Hebert, L. A. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.04.010 · Cited by 17 · see citing works

Chronic allograft nephropathy – a clinical syndrome: early detection and the potential role of proliferation signal inhibitors

Campistol, J. M., Boletis, I. N., Dantal, J., de Fijter, J. W., Hertig, A., Neumayer, H. H., Øyen, O. M., Pascual, J., Pohanka, E., Ruiz, J. C., et al. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01057.x · Cited by 17 · see citing works

A Prospective Open-Label Randomised Trial of Quinapril and/or Amlodipine in Progressive Non-Diabetic Renal Failure

MACGREGOR, M. S., Deighan, C. J., Rodger, R. S. C., & Boulton‐Jones, J. M. (2005) · Nephron Clinical Practice · doi:10.1159/000086714 · Cited by 17 · see citing works

Therapeutic measures in proteinuric nephropathy

Praga, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09925.x · Cited by 28 · see citing works

Reducing proteinuria GUIDELINES

(2005)

Renoprotection: One or many therapies?

Hebert, L. A., Wilmer, W. A., Falkenhain, M. E., Ladson-Wofford, S. E., Nahman, N. S., & Rovin, B. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041211.x · Cited by 185 · see citing works

The Progress of Nephrogenous Albuminuria Using Nonspecific Therapy

Jing-biao, X., & Liu, X. (2006) · Medical Recapitulate

Renoprotective Therapy in Patients With Nondiabetic Nephropathies

Pisoni, R., Ruggenenti, P. L., & Remuzzi, G. (2001) · Drugs · doi:10.2165/00003495-200161060-00003 · Cited by 18 · see citing works